NantHealth Competitors and Similar CompaniesClear all
NantHealth's competitors and similar companies include NantOmics, Synairgen, Quark Pharmaceuticals and BioMarker Strategies.
 NantHealth NantHealth is a healthcare company providing an evidence-based platform for healthcare diagnostics. |  Synairgen Synairgen is a respiratory drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic. |  Quark Pharmaceuticals Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics. |  BioMarker Strategies BioMarker Strategies offers SnapPath, a live tumor cell testing platform that improves the treatment of cancer. | ||
Founding Date | Founding Date 2007 | Founding Date 2012 | Founding Date N/A | Founding Date 1994 | Founding Date 2007 |
Type | Type Public | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations El Segundo, US HQ | Locations Culver City, US HQ | Locations Southampton, GB HQ | Locations Newark, US HQ | Locations Derwood, US HQ |
Employees | Employees 36512% increase | Employees 5 | Employees 36 | Employees 781% decrease | Employees 3 |
Valuation ($) | Valuation ($) 10.4 m | Valuation ($) N/A | Valuation ($) 12.4 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $67m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $28.8m (FY, 2022) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $38.2m (FY, 2022) | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit N/A |
Net income | Net income ($67.8m) (FY, 2022) | Net income N/A | Net income (£6.8m) (FY, 2024) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 250.8m (about 11 years ago) | Latest funding round N/A | Latest funding round $ 10m (almost 16 years ago) | Latest funding round $ 525k (over 9 years ago) |
Total funding raised | Total funding raised $ 547.5m | Total funding raised $ 250.8m | Total funding raised N/A | Total funding raised $ 37m | Total funding raised $ 5.7m |
For sources of this data, please see the company profile
View Company Profiles
NantOmics
HQ
Culver City, US
Employees
5
NantOmics is a molecular diagnostic testing company.
View companySynairgen
HQ
Southampton, GB
Employees
36
Synairgen is a respiratory drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic.
View companyQuark Pharmaceuticals
HQ
Newark, US
Employees
78↓ 1% decrease
Quark Pharmaceuticalsis a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.
View companyBioMarker Strategies
HQ
Derwood, US
Employees
3
BioMarker Strategies offers SnapPath, a live tumor cell testing platform that improves the treatment of cancer.
View company